![]() |
|
|
Vol. 286, Issue 2, 984-990, August 1998
Clinical Research Initiative and Division of Neuroscience and
Biomedical Systems (C.J.D., J.F.M., J.C.M.) and
Molecular Pharmacology
Group, Division of Biochemistry and Molecular Biology (G.M.), Institute
of Biomedical and Life Sciences, University of Glasgow, Glasgow G12
8QQ, Scotland, and
Quintiles Scotland Ltd., Inchwood, Bathgate,
Scotland (C.M.M.)
A fluorescent quinazoline derivative was shown to retain high affinity
for, and act as a competitive antagonist at, alpha-1 adrenoceptors. This allowed it to be used in live cells to localize receptors and to quantify receptor binding characteristics. The technique was demonstrated and validated on fibrobasts transfected with
a recombinant alpha-1d adrenoceptor. Using confocal
laser scanning microscopy and image analysis methods both diffuse and clustered binding sites were found: their binding characteristics were
assessed and found comparable to radioligand binding on membrane preparations. This approach should have widespread applicability in
nonradioactive assays determining the location, quantity and binding
properties of receptors and other biological molecules on live tissue.
This article has been cited by other articles:
![]() |
M. T.C.C. Patrao, D. B.C. Queiroz, G. Grossman, P. Petrusz, M. d. F. M. Lazari, and M. C. W. Avellar Cloning, expression and immunolocalization of {alpha}1-adrenoceptor in different tissues from rhesus monkey and human male reproductive tract Mol. Hum. Reprod., February 1, 2008; 14(2): 85 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Shafaroudi, M. McBride, C. Deighan, A. Wokoma, J. Macmillan, C. J. Daly, and J. C. McGrath Two "Knockout" Mouse Models Demonstrate That Aortic Vasodilatation Is Mediated via {alpha}2A-Adrenoceptors Located on the Endothelium J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 804 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Uberti, C. Hague, H. Oller, K. P. Minneman, and R. A. Hall Heterodimerization with {beta}2-Adrenergic Receptors Promotes Surface Expression and Functional Activity of {alpha}1D-Adrenergic Receptors J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 16 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Pediani, J. F. Colston, D. Caldwell, G. Milligan, C. J. Daly, and J. C. McGrath {beta}-Arrestin-Dependent Spontaneous {alpha}1a-Adrenoceptor Endocytosis Causes Intracellular Transportation of {alpha}-Blockers via Recycling Compartments Mol. Pharmacol., April 1, 2005; 67(4): 992 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Morris, R. R. Price, M. P. Smith, B. Lei, and D. A. Schwinn Cellular Trafficking of Human {alpha}1a-Adrenergic Receptors Is Continuous and Primarily Agonist-Independent Mol. Pharmacol., October 1, 2004; 66(4): 843 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ramsay, I. C. Carr, J. Pediani, J. F. Lopez-Gimenez, R. Thurlow, M. Fidock, and G. Milligan High-Affinity Interactions between Human {alpha}1A-Adrenoceptor C-Terminal Splice Variants Produce Homo- and Heterodimers but Do Not Generate the {alpha}1L-Adrenoceptor Mol. Pharmacol., August 1, 2004; 66(2): 228 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Uberti, R. A. Hall, and K. P. Minneman Subtype-Specific Dimerization of {alpha}1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties Mol. Pharmacol., December 1, 2003; 64(6): 1379 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Mackenzie, C. J. Daly, J. D. Pediani, and J. C. McGrath Quantitative Imaging in Live Human Cells Reveals Intracellular alpha 1-Adrenoceptor Ligand-Binding Sites J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 434 - 443. [Abstract] [Full Text] |
||||